Tim Coughlin

(Mr. Timothy Coughlin CPA)

Currently holds positions in Fate Therapeutics Inc, Retrophin Inc and aTyr Pharma Inc

Positions

Position Company Period
Independent Director Fate Therapeutics Inc Aug. 1, 2013 -
Independent Director Retrophin Inc March 31, 2015 -
Independent Director aTyr Pharma Inc April 7, 2017 -
Chief Financial Officer, Vice President Neurocrine Biosciences Inc Sept. 1, 2006 - Dec. 31, 2016
Tim Coughlin's trades of aTyr Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-05-30
B Purchase
50,000 +833.3%
1.75
USD 87,500 		50,000 +833.3% 1.75 USD 87,500
2022-06-06 2022-06-03
S Sale
1,439 -2.4%
22.81
USD 32,824 		1,439 -2.4% 22.81 USD 32,824
2017-02-08 2017-02-06
PS Planned sale
963 -0.7%
43.14
USD 41,544 		963 -0.7% 43.14 USD 41,544
2017-02-06 2017-02-03
PS Planned sale
1,500 -1.1%
42.55
USD 63,825 		1,500 -1.1% 42.55 USD 63,825
2017-01-18 2017-01-17
PS Planned sale
1,750 -1.3%
40.65
USD 71,138 		1,750 -1.3% 40.65 USD 71,138
2016-02-04 2016-02-03
PS Planned sale
1,500 -1.1%
38.06
USD 57,090 		1,500 -1.1% 38.06 USD 57,090
2016-01-21 2016-01-19
PS Planned sale
1,750 -1.3%
46.69
USD 81,708 		1,750 -1.3% 46.69 USD 81,708
2016-01-13 2016-01-11
PS Planned sale
1,750 -1.3%
44.25
USD 77,438 		1,750 -1.3% 44.25 USD 77,438
// ... existing code ... // ... rest of the file ...